Siniscalchi Antonio, Gallelli Luca, Palleria Caterina, De Sarro Giovambattista
Department of Neuroscience, Neurology Division, Annunziata Hospital, Cosenza, Italy.
Clin Neuropharmacol. 2009 Jul-Aug;32(4):230-1. doi: 10.1097/WNF.0b013e31819a68dc.
We describe a patient with idiopathic hemifacial spasm (HFS) that was responsive to zonisamide treatment.
A 65-year-old woman presented with a 4-year history of left-sided HFS developing gradually, starting from the upper facial muscles. After several analyses, the diagnosis of idiopathic HFS was made, and the clonazepam treatment (0.5 mg every 8 hours) was started, without a complete remission of symptoms. Therefore, zonisamide (150 mg twice a day for a 6-week period) was added, with a complete resolution. The rechallenge with zonisamide after its dechallenge confirmed its effectiveness. During follow-up, the patient remained symptom-free, with no adverse drug reactions.
We suggest that zonisamide could represent a useful therapeutic option in the treatment of idiopathic HFS.
我们描述了一名对唑尼沙胺治疗有反应的特发性面肌痉挛(HFS)患者。
一名65岁女性,有4年左侧HFS病史,起于上部面部肌肉,逐渐发展。经过多项分析,确诊为特发性HFS,开始使用氯硝西泮治疗(每8小时0.5毫克),症状未完全缓解。因此,加用唑尼沙胺(每天两次,每次150毫克,为期6周),症状完全缓解。停用唑尼沙胺后再次使用证实了其有效性。随访期间,患者无症状,无药物不良反应。
我们认为唑尼沙胺可能是治疗特发性HFS的一种有效治疗选择。